Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
4(57%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph early_phase_1
1
14%
Ph phase_1
1
14%
Ph phase_2
2
29%
Ph phase_3
1
14%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

4

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(1)
Terminated(2)

Detailed Status

Recruiting4
Completed1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
4
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)

Trials by Status

recruiting457%
completed114%
withdrawn114%
terminated114%

Recent Activity

4 active trials
Showing 5 of 7
recruitingphase_2

18F-mFBG Cardiac Uptake With Lewy Body Dementia

NCT07176286
recruiting

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

NCT06852807
recruiting

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

NCT06813742
completedphase_3

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

NCT04724369
withdrawnphase_2

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

NCT06233903
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07176286Phase 2

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Recruiting
NCT06852807

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

Recruiting
NCT06813742

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

Recruiting
NCT04724369Phase 3

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Completed
NCT06233903Phase 2

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Withdrawn
NCT05069220Early Phase 1

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Recruiting
NCT04258592Phase 1

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7